Case study co-authored by members of BridgeBio senior management and BridgeBio co-founder and MIT professor, Andrew W. Lo, Ph.D. - Case study features BridgeBio’s unique model that uses portfolio ...
BridgeBio Pharma, Inc. (NASDAQ: BBIO) shares lost ground at Tuesday’s opening. The Palo Alto, Calif.-based company, which claims to be “a new type of biopharmaceutical company focused on genetic ...